Unknown

Dataset Information

0

High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot.


ABSTRACT: Rett syndrome is a progressive neurodevelopmental disorder which affects almost exclusively girls, caused by variants in MECP2 gene. Effective therapies for this devastating disorder are not yet available and the need for tight regulation of MECP2 expression for brain to properly function makes gene replacement therapy risky. For this reason, gene editing with CRISPR/Cas9 technology appears as a preferable option for the development of new therapies. To study the disease, we developed and characterized a human neuronal model obtained by genetic reprogramming of patient-derived primary fibroblasts into induced Pluripotent Stem Cells. This cellular model represents an important source for our studies, aiming to correct MECP2 variants in neurons which represent the primarily affected cell type. We engineered a gene editing toolkit composed by a two-plasmid system to correct a hotspot missense variant in MECP2, c.473 C > T (p.(Thr158Met)). The first construct expresses the variant-specific sgRNA and the Donor DNA along with a fluorescent reporter system. The second construct brings Cas9 and targets for auto-cleaving, to avoid long-term Cas9 expression. NGS analysis on sorted cells from four independent patients demonstrated an exceptionally high editing efficiency, with up to 80% of HDR and less than 1% of indels in all patients, outlining the relevant potentiality of the approach for Rett syndrome therapy.

SUBMITTER: Croci S 

PROVIDER: S-EPMC7609331 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2023-08-11 | GSE225452 | GEO
| S-EPMC8861562 | biostudies-literature
2023-08-11 | GSE225450 | GEO
2023-08-11 | GSE225449 | GEO
| S-EPMC6914687 | biostudies-literature
| S-EPMC6391469 | biostudies-literature
| S-EPMC6425911 | biostudies-literature
| S-EPMC6807519 | biostudies-literature
| S-EPMC7064181 | biostudies-literature
| S-EPMC9226534 | biostudies-literature